Clinical Trials Logo

Rabies Post-exposure Prophylaxis clinical trials

View clinical trials related to Rabies Post-exposure Prophylaxis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05846568 Recruiting - Clinical trials for Rabies Post-exposure Prophylaxis

Study to Evaluate GR1801's Efficacy and Safety

Start date: October 21, 2022
Phase: Phase 3
Study type: Interventional

The goal of this clinical trial is to compare the efficacy and safety of GR1801 injection with Human Rabies Immunoglobulin(HRIG) in patients with WHO Category 3 rabies exposure. Patients will receive GR1801 injection or HRIG. Each group will receive rabies vaccine as the WHO Essen regime after Study Drug.